PPL
54
-5
GE
67
2
TSCO
49
5
UNP
52
7
ROK
62
15
NVDA
56
-4
NKE
36
6
SCHW
62
-2
WAT
55
2
TGT
22
2
GIS
31
3
PFG
45
3
HOG
35
2
KMB
39
2
HPE
63
2
DVN
21
3
HBI
59
4
FE
50
-2
LRCX
43
-2
TROW
56
5
PPL
54
-5
GE
67
2
TSCO
49
5
UNP
52
7
ROK
62
15
NVDA
56
-4
NKE
36
6
SCHW
62
-2
WAT
55
2
TGT
22
2
GIS
31
3
PFG
45
3
HOG
35
2
KMB
39
2
HPE
63
2
DVN
21
3
HBI
59
4
FE
50
-2
LRCX
43
-2
TROW
56
5
Financhill
Back

Context Therapeutics Vs. iBio Industry Stock Comparison

Sell
10

CNTX
Context Therapeutics

Last Price:
1.51
Seasonality Move:
-30%
Sell
43

IBIO
iBio

Last Price:
2.49
Seasonality Move:
-5.06%
Sell
10
Context Therapeutics (CNTX) is a Sell

Is Context Therapeutics a Buy, Sell or Hold?

  • The current Context Therapeutics [CNTX] share price is $1.39. The Score for CNTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • CNTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.64. The Score for IBIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNTX Stock Price Chart

What is Context Therapeutics's stock price today?

  • The Context Therapeutics share price today is $1.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNTX is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing slight buying pressure.

CNTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 23.23 Sell
Chaikin Money Flow: 392487 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.75 - 2.29) Sell
Bollinger Bands (100): (1.89 - 2.39) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 56.35 Buy
Chaikin Money Flow: 23623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.34 - 2.82) Buy
Bollinger Bands (100): (1.86 - 2.56) Buy

CNTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.7 Sell
20-day SMA: 1.98 Sell
50-day SMA: 2 Sell
200-day SMA: 1.83 Sell
8-day EMA: 1.66 Sell
20-day EMA: 1.86 Sell
50-day EMA: 2 Sell
200-day EMA: 1.85 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Buy
20-day SMA: 2.51 Buy
50-day SMA: 2.43 Buy
200-day SMA: 2.03 Buy
8-day EMA: 2.4 Buy
20-day EMA: 2.46 Buy
50-day EMA: 2.41 Buy
200-day EMA: 3.88 Sell

Context Therapeutics Earnings Growth & CNTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.21 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Context Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):